HU211105B - Process for producing 6-oxo-azepinoindole derivatives and pharmaceutical preparations containing them - Google Patents
Process for producing 6-oxo-azepinoindole derivatives and pharmaceutical preparations containing them Download PDFInfo
- Publication number
- HU211105B HU211105B HU9202430A HU9202430A HU211105B HU 211105 B HU211105 B HU 211105B HU 9202430 A HU9202430 A HU 9202430A HU 9202430 A HU9202430 A HU 9202430A HU 211105 B HU211105 B HU 211105B
- Authority
- HU
- Hungary
- Prior art keywords
- formula
- compounds
- compound
- alkyl
- hydrogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4125292A DE4125292A1 (de) | 1991-07-31 | 1991-07-31 | 6-oxo-azepinoindol-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| HU9202430D0 HU9202430D0 (en) | 1992-10-28 |
| HUT65453A HUT65453A (en) | 1994-06-28 |
| HU211105B true HU211105B (en) | 1995-10-30 |
Family
ID=6437366
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9202430A HU211105B (en) | 1991-07-31 | 1992-07-24 | Process for producing 6-oxo-azepinoindole derivatives and pharmaceutical preparations containing them |
| HU94P/P00032P HU210217A9 (en) | 1991-07-31 | 1994-09-30 | 6-oxo-azepinoindol compounds as well as a process and intermediate products for the production thereof, and drugs that contain these compounds |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU94P/P00032P HU210217A9 (en) | 1991-07-31 | 1994-09-30 | 6-oxo-azepinoindol compounds as well as a process and intermediate products for the production thereof, and drugs that contain these compounds |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US5272143A (enExample) |
| EP (1) | EP0525584B1 (enExample) |
| JP (1) | JP3174158B2 (enExample) |
| KR (1) | KR930002353A (enExample) |
| CN (2) | CN1069733A (enExample) |
| AT (1) | ATE161012T1 (enExample) |
| AU (1) | AU649153B2 (enExample) |
| CA (1) | CA2075102A1 (enExample) |
| CZ (1) | CZ239392A3 (enExample) |
| DE (2) | DE4125292A1 (enExample) |
| ES (1) | ES2110454T3 (enExample) |
| FI (1) | FI923440A7 (enExample) |
| HU (2) | HU211105B (enExample) |
| IE (1) | IE922310A1 (enExample) |
| IL (1) | IL102503A (enExample) |
| MX (1) | MX9204457A (enExample) |
| NO (1) | NO300375B1 (enExample) |
| NZ (1) | NZ243715A (enExample) |
| RU (1) | RU2078765C1 (enExample) |
| TW (1) | TW207541B (enExample) |
| ZA (1) | ZA925093B (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5414130A (en) * | 1993-12-23 | 1995-05-09 | The Dow Chemical Company | Process for the preparation of diaminoresorcinol |
| TR200102005T2 (tr) * | 1999-01-11 | 2001-12-21 | Agouron Pharmaceuticals,Inc. | Poli(adp-ribaz) polimerazların trisiklik inhibitörleri. |
| ECSP003637A (es) | 1999-08-31 | 2002-03-25 | Agouron Pharma | Inhibidores triciclicos de poli (adp-ribosa) polimerasas |
| EP1793830A2 (en) * | 2004-09-22 | 2007-06-13 | Pfizer, Inc. | Therapeutic combinations comprising poly(adp-ribose) polymerases inhibitor |
| KR100876520B1 (ko) * | 2004-09-22 | 2008-12-31 | 화이자 인코포레이티드 | 폴리(ａｄｐ-리보오스) 폴리머라제 억제제의 제조 방법 |
| CN102046176B (zh) | 2008-05-29 | 2013-08-07 | 阿尔巴尼分子研究公司 | 5-ht3受体调节剂、其制备方法和用途 |
| JP5745283B2 (ja) * | 2010-02-12 | 2015-07-08 | ファイザー・インク | ８−フルオロ−２−｛４−［（メチルアミノ）メチル］フェニル｝−１，３，４，５−テトラヒドロ−６Ｈ−アゼピノ［５，４，３−ｃｄ］インドール−６−オンの塩および多形体 |
| US10513515B2 (en) | 2017-08-25 | 2019-12-24 | Biotheryx, Inc. | Ether compounds and uses thereof |
| EP3830093A1 (en) | 2018-07-27 | 2021-06-09 | Biotheryx, Inc. | Bifunctional compounds as cdk modulators |
| US11897930B2 (en) | 2020-04-28 | 2024-02-13 | Anwita Biosciences, Inc. | Interleukin-2 polypeptides and fusion proteins thereof, and their pharmaceutical compositions and therapeutic applications |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4910193A (en) * | 1985-12-16 | 1990-03-20 | Sandoz Ltd. | Treatment of gastrointestinal disorders |
-
1991
- 1991-07-31 DE DE4125292A patent/DE4125292A1/de not_active Withdrawn
-
1992
- 1992-07-08 ZA ZA925093A patent/ZA925093B/xx unknown
- 1992-07-15 IE IE231092A patent/IE922310A1/en not_active Application Discontinuation
- 1992-07-15 IL IL10250392A patent/IL102503A/en not_active IP Right Cessation
- 1992-07-21 AT AT92112431T patent/ATE161012T1/de not_active IP Right Cessation
- 1992-07-21 DE DE59209055T patent/DE59209055D1/de not_active Expired - Fee Related
- 1992-07-21 ES ES92112431T patent/ES2110454T3/es not_active Expired - Lifetime
- 1992-07-21 EP EP92112431A patent/EP0525584B1/de not_active Expired - Lifetime
- 1992-07-24 NZ NZ243715A patent/NZ243715A/en unknown
- 1992-07-24 HU HU9202430A patent/HU211105B/hu not_active IP Right Cessation
- 1992-07-30 FI FI923440A patent/FI923440A7/fi not_active Application Discontinuation
- 1992-07-30 KR KR1019920013719A patent/KR930002353A/ko not_active Withdrawn
- 1992-07-30 MX MX9204457A patent/MX9204457A/es not_active IP Right Cessation
- 1992-07-30 JP JP20377092A patent/JP3174158B2/ja not_active Expired - Fee Related
- 1992-07-30 CN CN92108977A patent/CN1069733A/zh active Pending
- 1992-07-30 RU SU925052604A patent/RU2078765C1/ru active
- 1992-07-30 AU AU20677/92A patent/AU649153B2/en not_active Ceased
- 1992-07-30 NO NO923004A patent/NO300375B1/no unknown
- 1992-07-31 CZ CS922393A patent/CZ239392A3/cs unknown
- 1992-07-31 CA CA002075102A patent/CA2075102A1/en not_active Abandoned
- 1992-07-31 US US07/922,527 patent/US5272143A/en not_active Expired - Lifetime
- 1992-09-10 TW TW081107187A patent/TW207541B/zh active
-
1994
- 1994-09-30 HU HU94P/P00032P patent/HU210217A9/hu unknown
-
1996
- 1996-01-19 CN CN96100699A patent/CN1141773A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| TW207541B (enExample) | 1993-06-11 |
| NO923004L (no) | 1993-02-01 |
| NZ243715A (en) | 1995-03-28 |
| IL102503A0 (en) | 1993-01-14 |
| AU649153B2 (en) | 1994-05-12 |
| IL102503A (en) | 1995-12-31 |
| AU2067792A (en) | 1993-02-04 |
| HUT65453A (en) | 1994-06-28 |
| HU9202430D0 (en) | 1992-10-28 |
| NO923004D0 (no) | 1992-07-30 |
| ZA925093B (en) | 1993-04-28 |
| DE59209055D1 (de) | 1998-01-22 |
| MX9204457A (es) | 1993-05-01 |
| US5272143A (en) | 1993-12-21 |
| RU2078765C1 (ru) | 1997-05-10 |
| CZ239392A3 (en) | 1993-04-14 |
| CN1069733A (zh) | 1993-03-10 |
| DE4125292A1 (de) | 1993-02-04 |
| ATE161012T1 (de) | 1997-12-15 |
| HU210217A9 (en) | 1995-02-28 |
| JPH05202052A (ja) | 1993-08-10 |
| NO300375B1 (no) | 1997-05-20 |
| EP0525584B1 (de) | 1997-12-10 |
| JP3174158B2 (ja) | 2001-06-11 |
| FI923440A0 (fi) | 1992-07-30 |
| ES2110454T3 (es) | 1998-02-16 |
| IE922310A1 (en) | 1993-02-10 |
| KR930002353A (ko) | 1993-02-23 |
| FI923440A7 (fi) | 1993-02-01 |
| CA2075102A1 (en) | 1993-02-01 |
| CN1141773A (zh) | 1997-02-05 |
| EP0525584A1 (de) | 1993-02-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0303507B1 (en) | Indole derivatives | |
| US5037845A (en) | Indole derivative | |
| RU2134266C1 (ru) | Производные 5-арилиндола и их применение в качестве агонистов серотонина (5-нт1) | |
| US5834493A (en) | Indole derivatives as 5-HT1A and/or 5-HT2 ligands | |
| AU2003279230A1 (en) | AZAINDOLE DERIVATIVES AS INHIBITORS OF p38 KINASE | |
| EA001593B1 (ru) | Диазепино-индоловые ингибиторы фосфодиэстераз iv | |
| NZ230068A (en) | Indazole-3-carboxylic acid esters and amides of diaza compounds having 6,7, or 8 ring members: preparatory processes and pharmaceutical compositions | |
| KR20040075892A (ko) | 5-하이드록시트립타민-6 리간드로서의 인돌릴알킬아민유도체 | |
| HU211105B (en) | Process for producing 6-oxo-azepinoindole derivatives and pharmaceutical preparations containing them | |
| CA1266482A1 (en) | 6-oxygenated-1,3,4,5-tetrahydrobenz(cd)indol-4-amines | |
| EP1615634B1 (en) | Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists | |
| US20070010568A1 (en) | Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists | |
| KR100485020B1 (ko) | 옥타하이드로-2Ｈ-피리도[1,2-ａ]피라진 화합물, 이들의 제조방법 및 이들을 함유하는 약제학적 조성물 | |
| JPH0755948B2 (ja) | 置換環式スルファミド誘導体 | |
| US3859304A (en) | 6-halo-1-aminomethyl-1,2,3,4-tetrahydrocarbazoles | |
| US20040142940A1 (en) | Indole-type derivatives as inhibitors of p38 kinase | |
| JP2002534427A (ja) | ３，４−ジヒドロ−２ｈ−ベンゾ［１，４］オキサジニル−メチル［３−（１ｈ−インドール−３−イル）−アルキル］−アミン | |
| JP2002047287A (ja) | 芳香族誘導体 | |
| JPH09508637A (ja) | ５ｈｔ２ｂレセプタ拮抗薬縮合インドール | |
| EP0746556B1 (en) | Tricyclic compounds having affinity for the 5-ht1a receptor | |
| KR20000005226A (ko) | 항정신병성 약제로서의 헥사하이드로-피리도(4,3-b)인돌 유도체 | |
| JPH01102077A (ja) | ２，６‐メタノピロロ‐３‐ベンズアゾジン類 | |
| HU202225B (en) | Process for producing indole derivatives | |
| JPH08225571A (ja) | ６−アルコキシ−１ｈ−ベンゾトリアゾール−５−カルボキサミド誘導体及びその中間体並びに該化合物を含有する医薬組成物 | |
| HU199451B (en) | Process for producing 2-square brackets open /piperidin-4-yl/-methyl square brackets closed-1,2,3,4-tetrahydroisoquinoline derivatives and pharmaceutical compositions comprising same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HMM4 | Cancellation of final prot. due to non-payment of fee |